Palantir's Growth Machine Meets Its Match: A 97x P/ E and a Governance Gauntlet

Palantir beat Q1 estimates with 85% revenue surge, but high valuation, German exclusion, and activist human rights pressure drag stock 20% below January peak.

Palantir Technologies is wrestling with a contradiction that has become impossible for investors to ignore. The software giant posted an 85% revenue surge in the first quarter, blew past earnings estimates, and forecast another quarter of blistering growth. Yet its stock sits roughly a third below its 52-week high and has shed nearly a fifth of its value since January. The tension comes down to a simple equation: when a company trades at 97 times forward earnings, perfection is the minimum requirement — and Palantir is facing anything but perfect conditions.

The operational numbers are undeniably robust. Net income more than quadrupled year over year in the first quarter, with adjusted earnings per share landing at $0.33 against a consensus forecast of $0.28. Revenue hit $1.63 billion, topping expectations of $1.54 billion. The rule-of-40 metric — a gauge of growth plus profitability — clocked in at an eye-popping 145%. Management guided for second-quarter revenue of roughly $1.8 billion, well above the $1.68 billion analysts had penciled in. For the full year, the company sees sales of $7.65 billion to $7.66 billion, implying growth of about 71%. Remaining performance obligations, a forward-looking indicator, stood at $4.45 billion.

That sort of momentum would normally send a stock higher. But Palantir's elevated multiple leaves little room for disappointment or distraction, and distractions have been piling up. In Germany, a key government client, the Bundeswehr has excluded Palantir from its procurement process for a military cloud system. Digitalminister Karsten Wildberger has pushed for a long-term European alternative. Bundeswehr cyber chief Thomas Daum raised concerns about granting industrial personnel access to national military databases. Meanwhile, the French firm ChapsVision won a contract to supply data-analysis software to Germany's domestic intelligence agency. Palantir chief executive Alex Karp expressed surprise at the Bundeswehr's stance and defended his company's defence technologies.

Governance is the other front. At the annual general meeting on June 3, shareholders will vote on two activist proposals: one calling for enhanced disclosure of human rights due diligence in the defence business, and another demanding a full human rights impact assessment. Palantir's board has recommended voting against both, arguing that the company is not a data or surveillance firm and citing legal confidentiality constraints. The push comes from the Congregation of the Sisters of Saint Joseph of Peace, supported by the organisation Investor Advocates for Social Justice. New York's comptroller also called for an independent human rights review of Palantir's work with the Department of Homeland Security and ICE. The Dutch pension fund ABP has already divested, and public pension funds in several US states face similar pressure from beneficiaries.

These headwinds have split the analyst community more sharply than almost any other large-cap tech stock. Rosenblatt's John McPeake, who is meeting with Palantir management in New York on May 19, lifted his price target from $200 to $225, arguing that Palantir's ontology layer is a hard-to-replicate competitive moat. Wedbush is even more bullish at $230. On the bearish side, RBC Capital holds at $90, while DA Davidson cut its target from $180 to $165. The gap reflects deep disagreement about how much future growth is already priced in — and how much political friction could slow the engine.

Retail investors have been voting with their feet. In the week through May 13, net outflows from Palantir shares reached $82 million. Insider selling has also drawn attention: over the past 90 days, the ratio of insider sales to purchases stood at 9.3 to 1. Technically, the stock looks shaky — trading below its 50-day moving average of €124.15 and well under the 200-day line of €139.63, with a relative strength index of 54.3 that suggests no oversold bounce in sight.

For all the near-term noise, the longer-term case still hinges on execution. The second-quarter results, due in August, will be the next major test. Palantir needs to show that its backlog continues to convert into revenue and that the governance debate is a sideshow rather than a drag on core government and defence demand. Until then, the market seems content to let a blockbuster growth story sit in the penalty box — waiting for either the valuation to come down or the clouds to clear.